Published in Gastroenterol Res Pract on March 08, 2016
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med (2012) 52.99
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med (2012) 35.24
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature (2014) 10.49
The future of immune checkpoint therapy. Science (2015) 5.59
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology (2005) 3.63
Ipilimumab (anti-CTLA4 antibody) causes regression of metastatic renal cell cancer associated with enteritis and hypophysitis. J Immunother (2007) 3.32
Mechanisms of tissue injury in cryosurgery. Cryobiology (1998) 3.24
Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J Leukoc Biol (2006) 2.79
Phase I/II study of ipilimumab for patients with metastatic melanoma. J Clin Oncol (2008) 2.79
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial. Clin Cancer Res (2010) 2.73
Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol (2002) 2.31
Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer (2014) 2.26
In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res (2004) 2.06
Radiofrequency ablation induces antigen-presenting cell infiltration and amplification of weak tumor-induced immunity. Radiology (2009) 1.95
Molecular characteristics of immunogenic cancer cell death. Cell Death Differ (2007) 1.92
Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol (2010) 1.84
Liposomal doxorubicin increases radiofrequency ablation-induced tumor destruction by increasing cellular oxidative and nitrative stress and accelerating apoptotic pathways. Radiology (2010) 1.84
Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10. J Vasc Interv Radiol (2013) 1.76
Radiofrequency thermal ablation for hepatocellular carcinoma stimulates autologous NK-cell response. Gastroenterology (2010) 1.72
Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol (2006) 1.69
Influence of large peritumoral vessels on outcome of radiofrequency ablation of liver tumors. J Vasc Interv Radiol (2003) 1.69
Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology (2001) 1.53
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. Br J Cancer (2006) 1.50
Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res (2011) 1.47
Mechanisms of focal heat destruction of liver tumors. J Surg Res (2005) 1.45
Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol (2009) 1.44
Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses. Cancer Res (2006) 1.44
Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1α/VEGFA. PLoS One (2012) 1.42
Expression of heat shock proteins and heat shock protein messenger ribonucleic acid in human prostate carcinoma in vitro and in tumors in vivo. Cell Stress Chaperones (2005) 1.41
The molecular basis of cryosurgery. BJU Int (2005) 1.40
The danger theory: 20 years later. Front Immunol (2012) 1.38
Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res (2007) 1.37
Activation of tumor-specific T lymphocytes by radio-frequency ablation of the VX2 hepatoma in rabbits. Cancer Res (2003) 1.33
Improvement of tumor oxygenation by mild hyperthermia. Radiat Res (2001) 1.27
Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine. Cancer Res (2006) 1.26
Studies in cryo-immunology. I. The production of antibodies to urogenital tissue in consequence of freezing treatment. Immunology (1967) 1.26
Immune response against dying tumor cells. Adv Immunol (2004) 1.26
Prospects for cryo-immunotherapy in cases of metastasizing carcinoma of the prostate. Cryobiology (1971) 1.24
Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg (2009) 1.24
Immunologic response to cryoablation of breast cancer. Breast Cancer Res Treat (2005) 1.23
Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations. J Urol (1970) 1.18
Cryoablation: mechanism of action and devices. J Vasc Interv Radiol (2010) 1.15
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma. J Gastroenterol (2009) 1.09
"Wide local ablation" of localized breast cancer using high intensity focused ultrasound. J Surg Oncol (2007) 1.09
Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol (2010) 1.08
Oncogenesis: An "Off-Target" Effect of Radiofrequency Ablation. Radiology (2015) 1.07
Serum cytokine levels in response to hepatic cryoablation. J Surg Oncol (2007) 1.07
Route of administration of the TLR9 agonist CpG critically determines the efficacy of cancer immunotherapy in mice. PLoS One (2009) 1.07
Study of apoptosis and heat shock protein (HSP) expression in hepatocytes following radiofrequency ablation (RFA). J Surg Res (2005) 1.05
Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood (2008) 1.05
Therapeutic efficacy of percutaneous radiofrequency ablation versus microwave ablation for hepatocellular carcinoma. PLoS One (2013) 1.05
Radiofrequency ablation combined with liposomal quercetin to increase tumour destruction by modulation of heat shock protein production in a small animal model. Int J Hyperthermia (2011) 1.05
Heat shock protein expression induced by percutaneous radiofrequency ablation of hepatocellular carcinoma in vivo. Int J Oncol (2004) 1.02
Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation. Ann Surg (2000) 0.99
Armed response: how dying cells influence T-cell functions. Immunol Rev (2011) 0.99
Host antitumour immune responses to HIFU ablation. Int J Hyperthermia (2007) 0.99
Expansion of an ablated site and induction of apoptosis after microwave coagulation therapy in rat liver. J Hepatobiliary Pancreat Surg (2001) 0.98
Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol (2005) 0.97
Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine. Mol Ther (2009) 0.97
Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model. Cryobiology (2003) 0.96
Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity. Clin Cancer Res (2005) 0.96
Combination treatment with comprehensive cryoablation and immunotherapy in metastatic pancreatic cancer. Pancreas (2013) 0.93
Rate of freeze alters the immunologic response after cryoablation of breast cancer. Ann Surg Oncol (2009) 0.93
Imiquimod enhances the systemic immunity attained by local cryosurgery destruction of melanoma lesions. J Invest Dermatol (2007) 0.93
Liver Ablation: Best Practice. Radiol Clin North Am (2015) 0.92
Changes in interleukin-1β and 6 after hepatic microwave tissue ablation compared with radiofrequency, cryotherapy and surgical resections. Am J Surg (2010) 0.92
Immunological aspects of cryosurgery in general surgery. Cryobiology (1982) 0.92
Systemic inflammatory response and downmodulation of peripheral CD25+Foxp3+ T-regulatory cells in patients undergoing radiofrequency thermal ablation for lung cancer. Hum Immunol (2009) 0.90
Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation. Clin Cancer Res (2006) 0.90
Heat shock protein 70 expression following hepatic radiofrequency ablation is affected by adjacent vasculature. J Surg Res (2010) 0.89
RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol (2008) 0.89
Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. Surgery (2009) 0.87
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation. Int J Cancer (2010) 0.86
The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer. Int J Hyperthermia (2004) 0.85
Immunologic response to primary cryoablation of high-risk prostate cancer. Cryobiology (2008) 0.85
Hepatic Radiofrequency Ablation-induced Stimulation of Distant Tumor Growth Is Suppressed by c-Met Inhibition. Radiology (2015) 0.85
Radiofrequency ablation, heat shock protein 70 and potential anti-tumor immunity in hepatic and pancreatic cancers: a minireview. Hepatobiliary Pancreat Dis Int (2010) 0.85
Induction of specific cellular and humoral responses against renal cell carcinoma after combination therapy with cryoablation and granulocyte-macrophage colony stimulating factor: a pilot study. J Immunother (2011) 0.84
Response of experimental tumor systems to cryosurgery. Cryobiology (1972) 0.83
Enhanced tumor metastases in rats following cryosurgery of primary tumor. Gan (1982) 0.83
Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy. PLoS One (2015) 0.81
Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation. Laryngoscope (1973) 0.81
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. Cell Stress Chaperones (2011) 0.80
Regression of prostatic cancer following sequential cryotherapy to the prostate. J Urol (1972) 0.80
Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment. Tumour Biol (2015) 0.79
Hyperthermia and the cell nucleus. Radiat Res (1982) 0.79
Dual role of heat shock proteins (HSPs) in anti-tumor immunity. Curr Mol Med (2012) 0.79
Enhancement of experimental pulmonary metastasis and inhibition of subcutaneously transplanted tumor growth following cryosurgery. Anticancer Res (1999) 0.78
Pattern of carcinoembryonic antigen drop after laparoscopic radiofrequency ablation of liver metastasis from colorectal carcinoma. Cancer (2006) 0.76
Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcoma. Cancer Immunol Immunother (1988) 0.76
Heat stress induced cell death mechanisms in hepatocytes and hepatocellular carcinoma: in vitro and in vivo study. Lasers Surg Med (2014) 0.76
[An experimental study on the induction of anti-tumor immunological activity after cryosurgery for liver carcinoma, and the effect of concomitant immunotherapy with OK432]. Nihon Geka Gakkai Zasshi (1993) 0.75
Immunological analysis of enhanced spontaneous metastasis in WKA rats following cryosurgery. Anticancer Res (1998) 0.75